Helsinn, Chugai sales and marketing update

Chugai launched Akynzeo netupitant/palonosetron in the U.K. to prevent chemotherapy-induced nausea and vomiting (CINV). The cost of the fixed-dose combination of 300 mg netupitant, a neurokinin 1 (...